Zhuhai Trinomab Pharmaceutical Co., Ltd.

This study tested a new injection called TNM002 in 240 healthy Chinese adults to see if it can protect against tetanus as well as the standard treatment. Participants received a single shot of TNM002, standard tetanus immunoglobulin, or a placebo. The main goal was to measure the…

This study tested a new medicine called TNM001 to see if it can prevent serious lung infections caused by RSV in high-risk infants under 1 year old. About 315 babies received either the medicine or a placebo, and researchers tracked how many got sick over 270 days. The goal is to…